Breakthrough PTSD drug enters final testing phase
Disease control
Recruiting now
This study is testing whether a new medication called TSND-201 can help reduce symptoms of PTSD in adults. Researchers will compare two different doses of the medication against a placebo in 300 people who have had PTSD for at least 6 months and haven't gotten enough relief from …
Phase: PHASE3 • Sponsor: Transcend Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC